2017 American Transplant Congress
Safety of Liver Donation from Living Donors with Sickle Cell Trait.
Background:Living donor liver transplant (LDLT) is an important source of organs particularly with the cadaveric organ shortage. It is the main source of liver transplant…2017 American Transplant Congress
ABO-Incompatibility Using Ritiuximab Does Not Increase Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Background and aims: ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) has a high success rate. However, a difference in hepatocellular carcinoma (HCC) recurrence rates has…2017 American Transplant Congress
Incidence and Outcomes of Re-Explorations in Living Donor Liver Transplantation.
Introduction: Re-exploration in Living Donor Liver Transplantation(LDLT) is required in patients for various causes, bleeding being the commonest cause. The outcome of these patients is…2017 American Transplant Congress
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.
Background: Enhanced recovery after surgery protocol has proven its efficacy in many surgery fields in controlling pain and promoting early recovery . The implication of…2017 American Transplant Congress
Surgical Outcomes of Pair-Watch Suturing Technique (PWST) for Duct-To-Duct Biliary Anastomosis in an Attempt to Reduce the Biliary Complications in Living Donor Liver Transplantation.
Objectives:Biliary stricture is one of the major complications after living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction. To prevent biliary stenosis, we have adopted…2017 American Transplant Congress
A Donor BMI Greater Than 30 Is Not a Contraindication for Live Liver Donation.
Toronto General Hospital, University of Toronto, Toronto, Canada
Background & aims: The increased prevalence of obesity worldwide threatens the pool of potential living liver donors. While the negative effects of graft steatosis on…2017 American Transplant Congress
The 'W' Technique: A Safe and Reproducible Technique for Hepatic Arterial Reconstruction in Living Donor Liver Transplantation.
Liver Transplant and HPB Surgery, Kokilaben Dhirubhai Ambani Hospital, Mumbai, India
BackgroundReconstruction of the hepatic artery is technically challenging in living donor liver transplantation (LDLT). We describe outcomes of a safe and easily teachable technique.MethodsA prospectively…2017 American Transplant Congress
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
The rising prevalence of end-stage renal disease and chronic organ shortage calls more people upon to consider living kidney donation. The benefits for recipients and…2017 American Transplant Congress
Readmission and Reoperation After Living Donor Hepatectomy.
Background: Living donor liver transplantation remains the predominant option for patients with acute or chronic liver failure in many regions with poor cadaveric donation rates.…2017 American Transplant Congress
A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation.
Center for Liver Cancer, National Cancer Center, Goyang, Korea
Background: Plasmapheresis is a desensitization method used prior to ABO-incompatible (ABO-I) living donor liver transplantation (LDLT). However, studies on its usefulness in the rituximab era…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 18
- Next Page »